CN Patent
CN109620812B — 一种奥贝胆酸组合物的制备方法
Assigned to Zhejiang Huahai Pharmaceutical Co Ltd · Expires 2023-07-21 · 3y expired
What this patent protects
本发明提供了一种奥贝胆酸组合物的制备方法,该组合物由奥贝胆酸和药用上可接受的辅料组成,其制备方法包括:将奥贝胆酸和药用辅料用湿法制粒锅进行预混合,然后进行干法造粒得到成奥贝胆酸组合物。该制备方法,有效地解决了体外溶出实验终点完全溶出较依赖于奥贝胆酸粒径及混合工序的问题,简化了生产工艺,提高了生产效率,更适合工业化生产。
USPTO Abstract
本发明提供了一种奥贝胆酸组合物的制备方法,该组合物由奥贝胆酸和药用上可接受的辅料组成,其制备方法包括:将奥贝胆酸和药用辅料用湿法制粒锅进行预混合,然后进行干法造粒得到成奥贝胆酸组合物。该制备方法,有效地解决了体外溶出实验终点完全溶出较依赖于奥贝胆酸粒径及混合工序的问题,简化了生产工艺,提高了生产效率,更适合工业化生产。
Drugs covered by this patent
- Ocaliva (OBETICHOLIC ACID) · Intercept Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.